1Klotz U.Tramadol-the impact of its pharma cokinetic and pharmacodynamic properties on the clinical management of pain.Araneimittelforschung, 2003,53(10):681-7.
3Liu ZM, Zhou WH, Lian Z, et al. Drug dependence and abuse potential of tramadol Zbongguo Yao Li Xue Bao. 1999 Jan, 20 (1): 52-4.
4Roulihan DJ. Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. Ann pharmadother, 2004 Mar. 38(3):411-3.
5Barann M, Urban B, Dtamer u, et al. Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors:a possible mechanism for tramadol-induced early emesis. Eur J Pharmacol. 2006 Feb 15.531 (1-3):54-8. Epub 2006 Jan 19.
6Kranta MJ,G arcia JA,Mehler PS.Tramadol-associated pericarditis. Int J Cardiol. 2005 Mar 30,99(3):497-8.
